Literature DB >> 9778661

Role of the basolateral nucleus of the amygdala in the formation of a phobia.

S E File1, L E Gonzalez, R Gallant.   

Abstract

Specific phobia is an anxiety disorder that does not respond to benzodiazepines. The elevated plus-maze test of anxiety is sensitive to benzodiazepines on trial 1, but during the first 5-min trial the nature of the anxiety generated changes to a specific fear of heights, and, as a result, on trial 2 the rats no longer respond to benzodiazepines. However, rats that received reversible bilateral lesions of the basolateral amygdala (by lidocaine injection) immediately after trial 1 responded with an anxiolytic response to chlordiazepoxide when tested 48 h later on trial 2. Those that received vehicle injections after trial 1 showed the usual lack of response to chlordiazepoxide on trial 2. Thus, the basolateral amygdala plays a crucial role in the consolidation of information that leads to the formation of a specific phobia and subsequent insensitivity to benzodiazepines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9778661     DOI: 10.1016/S0893-133X(98)00035-9

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  10 in total

Review 1.  Contextual conditioning in rats as an animal model for generalized anxiety disorder.

Authors:  Laura Luyten; Debora Vansteenwegen; Kris van Kuyck; Loes Gabriëls; Bart Nuttin
Journal:  Cogn Affect Behav Neurosci       Date:  2011-06       Impact factor: 3.282

2.  Increased anxiety and synaptic plasticity in estrogen receptor beta -deficient mice.

Authors:  W Krezel; S Dupont; A Krust; P Chambon; P F Chapman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-02       Impact factor: 11.205

3.  Reciprocal activation/inactivation of ERK in the amygdala and frontal cortex is correlated with the degree of novelty of an open-field environment.

Authors:  Frederico Velasco Sanguedo; Caio Vitor Bueno Dias; Flavia Regina Cruz Dias; Richard Ian Samuels; Robert J Carey; Marinete Pinheiro Carrera
Journal:  Psychopharmacology (Berl)       Date:  2015-12-19       Impact factor: 4.530

4.  Activation of amygdalar metabotropic glutamate receptors modulates anxiety, and risk assessment behaviors in ovariectomized estradiol-treated female rats.

Authors:  María De Jesús-Burgos; Vanessa Torres-Llenza; Nivia L Pérez-Acevedo
Journal:  Pharmacol Biochem Behav       Date:  2012-01-24       Impact factor: 3.533

5.  Injured brain regions associated with anxiety in Vietnam veterans.

Authors:  Kristine M Knutson; Shana T Rakowsky; Jeffrey Solomon; Frank Krueger; Vanessa Raymont; Michael C Tierney; Eric M Wassermann; Jordan Grafman
Journal:  Neuropsychologia       Date:  2013-01-15       Impact factor: 3.139

6.  Comparison of the activation of somatostatin- and neuropeptide Y-containing neuronal populations of the rat amygdala following two different anxiogenic stressors.

Authors:  Ryan K Butler; L Casey White; Dani Frederick-Duus; Kris F Kaigler; Jim R Fadel; Marlene A Wilson
Journal:  Exp Neurol       Date:  2012-08-17       Impact factor: 5.330

7.  The biology of fear- and anxiety-related behaviors.

Authors:  Thierry Steimer
Journal:  Dialogues Clin Neurosci       Date:  2002-09       Impact factor: 5.986

8.  Object Phobia and Altered RhoA Signaling in Amygdala of Mice Lacking RICH2.

Authors:  Tasnuva Sarowar; Stefanie Grabrucker; Tobias M Boeckers; Andreas M Grabrucker
Journal:  Front Mol Neurosci       Date:  2017-06-08       Impact factor: 5.639

9.  Hippocampal acetylcholine depletion has no effect on anxiety, spatial novelty preference, or differential reward for low rates of responding (DRL) performance in rats.

Authors:  Stephen B McHugh; Anna Francis; J Devin McAuley; Amanda L Stewart; Mark G Baxter; David M Bannerman
Journal:  Behav Neurosci       Date:  2015-08       Impact factor: 1.912

Review 10.  Rho GTPases in the Amygdala-A Switch for Fears?

Authors:  Tasnuva Sarowar; Andreas M Grabrucker
Journal:  Cells       Date:  2020-08-26       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.